Filing Flows › Amgen (AMGN) › Who owns the stock
Who owns Amgen (AMGN) stock
3,078 funds reported Amgen (AMGN) shares in their latest 13F filings, worth $175.2B in all. The largest holder is Vanguard Group ($17.9B). Last quarter 1,291 funds added to their stakes and 1213 cut them. Members of Congress and other officials disclosed 11 trades (4 buys, 7 sales).
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Group | 54,838,826 | $17.9B | increase | 2025-12-31 |
| BlackRock | 49,362,016 | $17.9B | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 35,250,101 | $12.8B | increase | 2026-06-30 |
| State Street | 30,560,537 | $11.1B | increase | 2026-06-30 |
| Capital World Investors | 29,075,329 | $10.5B | decrease | 2026-06-30 |
| Invesco | 16,320,446 | $5.9B | increase | 2026-06-30 |
| Geode Capital Management, LLC | 15,696,068 | $5.7B | increase | 2026-06-30 |
| Charles Schwab Investment Management | 15,034,038 | $5.4B | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 14,853,366 | $5.4B | increase | 2026-06-30 |
| Morgan Stanley | 13,653,692 | $4.9B | decrease | 2026-06-30 |
| Wells Fargo | 7,235,462 | $2.6B | increase | 2026-06-30 |
| Primecap Management | 6,756,962 | $2.4B | decrease | 2026-06-30 |
| Capital Research Global Investors | 6,272,625 | $2.3B | decrease | 2026-06-30 |
| Northern Trust | 6,200,994 | $2.2B | decrease | 2026-06-30 |
| UBS AM, a distinct business unit of UBS Asset Management Americas LLC | 5,390,910 | $2.0B | increase | 2026-06-30 |
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2026-09-22 | David J. Taylor | purchase | $1K–$15K |
| 2026-08-26 | David J. Taylor | sale | $1K–$15K |
| 2026-08-12 | Sheldon Whitehouse | partial sale | $1K–$15K |
| 2026-06-05 | David J. Taylor | purchase | $1K–$15K |
| 2026-04-17 | Maria Elvira Salazar | sale | $15K–$50K |
| 2026-03-27 | Alan Armstrong | sale | $15K–$50K |
| 2026-03-24 | Maria Elvira Salazar | purchase | $15K–$50K |
| 2026-02-26 | David J. Taylor | sale | $1K–$15K |
| 2026-01-29 | David J. Taylor | sale | $1K–$15K |
| 2026-01-16 | David J. Taylor | purchase | $1K–$15K |
Amgen's latest quarter
Amgen, Q3 2026: revenue $10.4B (+8% year over year), operating margin 35.8%, net earnings $3.9B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most AMGN stock?
By the latest 13F filings: Vanguard Group ($17.9B); BlackRock ($17.9B); Vanguard Capital Management LLC ($12.8B); State Street ($11.1B); Capital World Investors ($10.5B).
Has Congress traded AMGN stock?
Officials disclosed 11 trades on file: 4 buys and 7 sales. The latest: David J. Taylor, purchase on 2026-09-22.
What is the short interest in AMGN?
13,378,638 shares were sold short at the 2026-10-15 settlement, -4.63% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.